Last 12 months
Inside the activity.
1 purchase rows · 142 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 48 |
| Jan 2026 | 0 | 6 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 6 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 24 |
| Jun 2026 | 1 | 26 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 17 |
| Sep 2026 | 0 | 8 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 15, 2022 Filed Sep 8, 2022 20:05 UTC |
EAGLE CRAIGCHIEF MEDICAL OFFICER
|
Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 3,717 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000075 · wf-form4_166266753579265.xml · derivative · entry 3 EAGLE CRAIG · CIK 0001562135 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,153 Underlying: COMMON STOCK · 3,717 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on May 15, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each anniversary of May 15, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
| May 15, 2022 Filed Sep 8, 2022 20:05 UTC |
EAGLE CRAIGCHIEF MEDICAL OFFICER
|
Tax withholdingCOMMON STOCK | 1,286 | $35.91 | $46,180.26 |
DisclosureSEC source: 0001576280-22-000075 · wf-form4_166266753579265.xml · nonDerivative · entry 2 EAGLE CRAIG · CIK 0001562135 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,431 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| May 15, 2022 Filed Sep 8, 2022 20:05 UTC |
EAGLE CRAIGCHIEF MEDICAL OFFICER
|
Exercise / conversionCOMMON STOCK | 3,717 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000075 · wf-form4_166266753579265.xml · nonDerivative · entry 1 EAGLE CRAIG · CIK 0001562135 · CHIEF MEDICAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,717 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 09, 2022 Filed May 26, 2022 20:13 UTC |
Bell Michael BrianCHIEF FINANCIAL OFFICER
|
GrantRESTRICTED STOCK UNITS · Derivative | 19,727 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000032 · wf-form4_165359596223153.xml · derivative · entry 2 Bell Michael Brian · CIK 0001702824 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,727 Underlying: COMMON STOCK · 19,727 shares Expires not disclosed F2 · derivative.exercise_date: This represents a restricted stock unit award granted on May 09,2022 that vests over a four-year period. 25% of the shares subject to such award vests on March 15, 2023 and the remaining 75% of the shares vests in equal quarterly installments over the remaining three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| May 09, 2022 Filed May 26, 2022 20:13 UTC |
Bell Michael BrianCHIEF FINANCIAL OFFICER
|
GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 39,454 | $0.00 Strike: $30.63 | $0.00 |
DisclosureSEC source: 0001576280-22-000032 · wf-form4_165359596223153.xml · derivative · entry 1 Bell Michael Brian · CIK 0001702824 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,454 Underlying: COMMON STOCK · 39,454 shares Expires 2032-05-09 F1 · derivative.exercise_date: This represents a stock option granted on May 09, 2022 that vests over a four-year period. 25% of the shares subject to such award vests on February 18, 2023 and the remaining 75% of the shares vests in equal monthly installments over the remaining three-year period thereafter. Read SEC document |
| April 15, 2022 Filed Apr 19, 2022 20:40 UTC |
Saia John G.See Remarks
|
Tax withholdingCOMMON STOCK | 1,102 | $71.99 | $79,332.98 |
DisclosureSEC source: 0001576280-22-000018 · wf-form4_165040080476333.xml · nonDerivative · entry 1 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,291 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:17 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 4,934 | $5.94 Strike: $5.94 | $29,307.96 |
DisclosureSEC source: 0000899243-22-010947 · doc4.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,869 Underlying: COMMON STOCK · 4,934 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:17 UTC |
MERESMAN STANLEY JDirector
|
SaleCOMMON STOCK | 4,934 | $58.74 | $289,823.16 |
DisclosureSEC source: 0000899243-22-010947 · doc4.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| March 10, 2022 Filed Mar 14, 2022 20:17 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionCOMMON STOCK | 4,934 | $5.94 | $29,307.96 |
DisclosureSEC source: 0000899243-22-010947 · doc4.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 16:27 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 4,934 | $5.94 Strike: $5.94 | $29,307.96 |
DisclosureSEC source: 0001576280-22-000007 · wf-form4_164487404802454.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,803 Underlying: COMMON STOCK · 4,934 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 16:27 UTC |
MERESMAN STANLEY JDirector
|
SaleCOMMON STOCK | 4,934 | $73.80 | $364,129.20 |
DisclosureSEC source: 0001576280-22-000007 · wf-form4_164487404802454.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| February 10, 2022 Filed Feb 14, 2022 16:27 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionCOMMON STOCK | 4,934 | $5.94 | $29,307.96 |
DisclosureSEC source: 0001576280-22-000007 · wf-form4_164487404802454.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 15, 2022 Filed Jan 18, 2022 21:38 UTC |
Bell Michael BrianCHIEF FINANCIAL OFFICER
|
Exercise / conversionRESTRICTED STOCK UNITS · Derivative | 3,308 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000004 · wf-form4_164254189903908.xml · derivative · entry 3 Bell Michael Brian · CIK 0001702824 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,926 Underlying: COMMON STOCK · 3,308 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on January 15, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each anniversary of January 15, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable for Restricted Stock Units. Read SEC document |
| January 15, 2022 Filed Jan 18, 2022 21:38 UTC |
Bell Michael BrianCHIEF FINANCIAL OFFICER
|
Tax withholdingCOMMON STOCK | 1,246 | $77.58 | $96,664.68 |
DisclosureSEC source: 0001576280-22-000004 · wf-form4_164254189903908.xml · nonDerivative · entry 2 Bell Michael Brian · CIK 0001702824 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,062 F1 · shares: These shares were retained by the Company in order to meet the tax withholding obligations of the award-holder in connection with the vesting of an installment of the restricted stock units. The amount retained by the Company was not in excess of the amount of the tax liability. Read SEC document |
| January 15, 2022 Filed Jan 18, 2022 21:38 UTC |
Bell Michael BrianCHIEF FINANCIAL OFFICER
|
GrantCOMMON STOCK | 3,308 | $0.00 | $0.00 |
DisclosureSEC source: 0001576280-22-000004 · wf-form4_164254189903908.xml · nonDerivative · entry 1 Bell Michael Brian · CIK 0001702824 · CHIEF FINANCIAL OFFICER 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,308 Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 16:16 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 4,934 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001576280-22-000003 · wf-form4_164202220001477.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,737 Underlying: COMMON STOCK · 4,934 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 16:16 UTC |
MERESMAN STANLEY JDirector
|
SaleCOMMON STOCK | 4,934 | $86.08 | $424,718.72 |
DisclosureSEC source: 0001576280-22-000003 · wf-form4_164202220001477.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| January 10, 2022 Filed Jan 12, 2022 16:16 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionCOMMON STOCK | 4,934 | $5.94 | $29,307.96 |
DisclosureSEC source: 0001576280-22-000003 · wf-form4_164202220001477.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 17:46 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 4,934 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001576280-21-000111 · wf-form4_163952196765589.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,671 Underlying: COMMON STOCK · 4,934 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 17:46 UTC |
MERESMAN STANLEY JDirector
|
SaleCOMMON STOCK | 4,934 | $95.59 | $471,641.06 |
DisclosureSEC source: 0001576280-21-000111 · wf-form4_163952196765589.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| December 10, 2021 Filed Dec 14, 2021 17:46 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionCOMMON STOCK | 4,934 | $5.94 | $29,307.96 |
DisclosureSEC source: 0001576280-21-000111 · wf-form4_163952196765589.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 00:07 UTC |
Talasaz AmirAliDirector · Co-Chief Executive Officer
|
PurchaseCOMMON STOCK | 100 | $98.00 | $9,800.00 |
DisclosureSEC source: 0001576280-21-000108 · wf-form4_163771240170350.xml · nonDerivative · entry 8 Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,853,845 Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 00:07 UTC |
Talasaz AmirAliDirector · Co-Chief Executive Officer
|
PurchaseCOMMON STOCK | 14,900 | $96.83 | $1,442,774.45 |
DisclosureSEC source: 0001576280-21-000108 · wf-form4_163771240170350.xml · nonDerivative · entry 7 Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,853,745 F5 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $96.50 to $97.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 00:07 UTC |
Talasaz AmirAliDirector · Co-Chief Executive Officer
|
PurchaseCOMMON STOCK | 5,000 | $95.50 | $477,500.00 |
DisclosureSEC source: 0001576280-21-000108 · wf-form4_163771240170350.xml · nonDerivative · entry 6 Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,838,845 Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 00:07 UTC |
Talasaz AmirAliDirector · Co-Chief Executive Officer
|
PurchaseCOMMON STOCK | 5,000 | $94.00 | $470,000.00 |
DisclosureSEC source: 0001576280-21-000108 · wf-form4_163771240170350.xml · nonDerivative · entry 5 Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,833,845 Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 00:07 UTC |
Talasaz AmirAliDirector · Co-Chief Executive Officer
|
PurchaseCOMMON STOCK | 23,467 | $93.05 | $2,183,637.20 |
DisclosureSEC source: 0001576280-21-000108 · wf-form4_163771240170350.xml · nonDerivative · entry 4 Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,828,845 F4 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $92.915 to $93.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 00:07 UTC |
Talasaz AmirAliDirector · Co-Chief Executive Officer
|
PurchaseCOMMON STOCK | 6,033 | $92.42 | $557,569.26 |
DisclosureSEC source: 0001576280-21-000108 · wf-form4_163771240170350.xml · nonDerivative · entry 3 Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,805,378 F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $91.885 to $92.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 00:07 UTC |
Eltoukhy HelmyDirector · Co-Chief Executive Officer
|
PurchaseCOMMON STOCK | 100 | $98.00 | $9,800.00 |
DisclosureSEC source: 0001576280-21-000109 · wf-form4_163771242610324.xml · nonDerivative · entry 8 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,956,186 Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 00:07 UTC |
Eltoukhy HelmyDirector · Co-Chief Executive Officer
|
PurchaseCOMMON STOCK | 14,900 | $96.83 | $1,442,774.45 |
DisclosureSEC source: 0001576280-21-000109 · wf-form4_163771242610324.xml · nonDerivative · entry 7 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,956,086 F5 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $96.50 to $97.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 00:07 UTC |
Eltoukhy HelmyDirector · Co-Chief Executive Officer
|
PurchaseCOMMON STOCK | 5,000 | $95.50 | $477,500.00 |
DisclosureSEC source: 0001576280-21-000109 · wf-form4_163771242610324.xml · nonDerivative · entry 6 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,941,186 Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 00:07 UTC |
Eltoukhy HelmyDirector · Co-Chief Executive Officer
|
PurchaseCOMMON STOCK | 5,000 | $94.00 | $470,000.00 |
DisclosureSEC source: 0001576280-21-000109 · wf-form4_163771242610324.xml · nonDerivative · entry 5 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,936,186 Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 00:07 UTC |
Eltoukhy HelmyDirector · Co-Chief Executive Officer
|
PurchaseCOMMON STOCK | 26,394 | $93.04 | $2,455,811.25 |
DisclosureSEC source: 0001576280-21-000109 · wf-form4_163771242610324.xml · nonDerivative · entry 4 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,931,186 F4 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $92.88 to $93.35, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 23, 2021 Filed Nov 24, 2021 00:07 UTC |
Eltoukhy HelmyDirector · Co-Chief Executive Officer
|
PurchaseCOMMON STOCK | 3,106 | $92.23 | $286,481.29 |
DisclosureSEC source: 0001576280-21-000109 · wf-form4_163771242610324.xml · nonDerivative · entry 3 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,904,792 F3 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $91.88 to $92.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 19, 2021 Filed Nov 24, 2021 00:07 UTC |
Talasaz AmirAliDirector · Co-Chief Executive Officer
|
PurchaseCOMMON STOCK | 12,279 | $98.78 | $1,212,978.56 |
DisclosureSEC source: 0001576280-21-000108 · wf-form4_163771240170350.xml · nonDerivative · entry 2 Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,799,345 F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $98.75 to $99.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 19, 2021 Filed Nov 24, 2021 00:07 UTC |
Talasaz AmirAliDirector · Co-Chief Executive Officer
|
PurchaseCOMMON STOCK | 37,721 | $97.82 | $3,689,962.52 |
DisclosureSEC source: 0001576280-21-000108 · wf-form4_163771240170350.xml · nonDerivative · entry 1 Talasaz AmirAli · CIK 0001753159 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,787,066 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $97.64 to $98.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 19, 2021 Filed Nov 24, 2021 00:07 UTC |
Eltoukhy HelmyDirector · Co-Chief Executive Officer
|
PurchaseCOMMON STOCK | 12,409 | $98.75 | $1,225,445.83 |
DisclosureSEC source: 0001576280-21-000109 · wf-form4_163771242610324.xml · nonDerivative · entry 2 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,901,686 F2 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $98.71 to $98.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 19, 2021 Filed Nov 24, 2021 00:07 UTC |
Eltoukhy HelmyDirector · Co-Chief Executive Officer
|
PurchaseCOMMON STOCK | 37,591 | $97.90 | $3,680,316.78 |
DisclosureSEC source: 0001576280-21-000109 · wf-form4_163771242610324.xml · nonDerivative · entry 1 Eltoukhy Helmy · CIK 0001752968 · Director · Co-Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,889,277 F1 · price: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $97.445 to $98.25, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 16:13 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 4,934 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001576280-21-000107 · wf-form4_163675155043943.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,605 Underlying: COMMON STOCK · 4,934 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 16:13 UTC |
MERESMAN STANLEY JDirector
|
SaleCOMMON STOCK | 4,934 | $106.38 | $524,878.92 |
DisclosureSEC source: 0001576280-21-000107 · wf-form4_163675155043943.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| November 10, 2021 Filed Nov 12, 2021 16:13 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionCOMMON STOCK | 4,934 | $5.94 | $29,307.96 |
DisclosureSEC source: 0001576280-21-000107 · wf-form4_163675155043943.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:32 UTC |
POTTER MYRTLE SDirector
|
GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 5,613 | $0.00 Strike: $110.43 | $0.00 |
DisclosureSEC source: 0001576280-21-000106 · wf-form4_163658353555237.xml · derivative · entry 2 POTTER MYRTLE S · CIK 0001214130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,613 Underlying: COMMON STOCK · 5,613 shares Expires 2031-11-07 F3 · derivative.exercise_date: The stock option vest as to 25% of the shares subject to such award on October 15, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of October 15, 2022, during the three-year period thereafter. Read SEC document |
| November 08, 2021 Filed Nov 10, 2021 22:32 UTC |
POTTER MYRTLE SDirector
|
GrantRESTRICTED STOCK UNITS · Derivative | 3,283 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-21-000106 · wf-form4_163658353555237.xml · derivative · entry 1 POTTER MYRTLE S · CIK 0001214130 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,283 Underlying: COMMON STOCK · 3,283 shares Expires not disclosed F1 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on October 15, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of October 15, 2022, during the three-year period thereafter. F2 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 20:13 UTC |
Saia John G.See Remarks
|
GrantRESTRICTED STOCK UNITS · Derivative | 4,209 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001576280-21-000100 · wf-form4_163605677149062.xml · derivative · entry 2 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,209 Underlying: COMMON STOCK · 4,209 shares Expires not disclosed F2 · derivative.exercise_date: The restricted stock unit vests as to 25% of the shares subject to such award on September 1, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each quarterly anniversary of September 1, 2022, during the three-year period thereafter. F3 · derivative.expiration_date: Not applicable to Restricted Stock Units. Read SEC document |
| November 02, 2021 Filed Nov 4, 2021 20:13 UTC |
Saia John G.See Remarks
|
GrantSTOCK OPTION (RIGHT TO BUY) · Derivative | 8,418 | $0.00 Strike: $117.61 | $0.00 |
DisclosureSEC source: 0001576280-21-000100 · wf-form4_163605677149062.xml · derivative · entry 1 Saia John G. · CIK 0001737840 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,418 Underlying: COMMON STOCK · 8,418 shares Expires 2031-11-01 F1 · derivative.exercise_date: The stock option vests as to 25% of the shares subject to such award on September 1, 2022, and as to the remaining 75% of the shares subject to such award in substantially equal installments on each monthly anniversary of September 1, 2022, during the three-year period thereafter. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 17:03 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 4,934 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001576280-21-000091 · wf-form4_163415898172259.xml · derivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,539 Underlying: COMMON STOCK · 4,934 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 17:03 UTC |
MERESMAN STANLEY JDirector
|
SaleCOMMON STOCK | 4,934 | $103.59 | $511,113.06 |
DisclosureSEC source: 0001576280-21-000091 · wf-form4_163415898172259.xml · nonDerivative · entry 2 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 17:03 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionCOMMON STOCK | 4,934 | $5.94 | $29,307.96 |
DisclosureSEC source: 0001576280-21-000091 · wf-form4_163415898172259.xml · nonDerivative · entry 1 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,993 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 17:07 UTC |
MERESMAN STANLEY JDirector
|
Exercise / conversionSTOCK OPTION (RIGHT TO BUY) · Derivative | 4,934 | $0.00 Strike: $5.94 | $0.00 |
DisclosureSEC source: 0001576280-21-000090 · wf-form4_163165363552010.xml · derivative · entry 5 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,473 Underlying: COMMON STOCK · 4,934 shares Expires 2028-05-09 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The stock option vests and becomes exercisable in equal monthly installments over 48 months commencing on May 10, 2018. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 17:07 UTC |
MERESMAN STANLEY JDirector
|
SaleCOMMON STOCK | 800 | $131.12 | $104,896.00 |
DisclosureSEC source: 0001576280-21-000090 · wf-form4_163165363552010.xml · nonDerivative · entry 4 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,059 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. Read SEC document |
| September 10, 2021 Filed Sep 14, 2021 17:07 UTC |
MERESMAN STANLEY JDirector
|
SaleCOMMON STOCK | 1,082 | $130.11 | $140,780.75 |
DisclosureSEC source: 0001576280-21-000090 · wf-form4_163165363552010.xml · nonDerivative · entry 3 MERESMAN STANLEY J · CIK 0001283102 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,859 F1 · shares: These shares were sold under a pre-arranged sales plan pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $129.86 to $130.46, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.